Lipitor Faces Tough Competition From Generic Versions

.

Lipitor Faces Tough Competition From Generic Versions

In a recent report, it has been made clear that the sales of cholesterol blockbuster Lipitor have tumbled down by 50% in a single week as the market is flooded with new prescriptions for generic Lipitor. Though stern efforts were made by Lipitor maker Pfizer to ensure that patients stray with their pull, it was observed that majority of the patients had switched their preference.

It has been known that the makers had lost patent protection on November 30 in the U. S, after which there were many generic versions making way in the market. It was said that after the decision, India's Ranbaxy Laboratories along with Pfizer released generic version in the market thereby ensuring that there is going to be tough competition to the makers of Lipitor in the coming time.

There was significant attention given to this case across the industry as it was found that there have been many cases where generic drugs pose serious competition to accrual drug makers, thereby imposing escalated loss of revenue over the coming few years. It has been made clear from the data firm IMS Health on prescriptions for Lipitor and other drugs which could lower LDL or bad cholesterol, that there is significant decrease in number of drugs to 359,235 in the seven days ended December 9, as compared to 724,799 Lipitor prescriptions filled a month earlier.

In response to the news, shares of Lipitor moved down to 9.7% from 20.7% over that period. However, there has been report that owing to a new Crestor ad campaign, Crestor from Britain's AstraZeneca PLC had been able to retain market share of 12.3%.

There has been rise in the number of prescriptions filled from November 11 to December 9 of generic versions of three older statins - Zocor, Pravachol and Mevacor, as compare to Lipitor and Crestor.


Latest News

Yelp Trims Third Quarter Earnings Forecast Also Announces Departure of Its Chair
Solvay, the Belgian Chemical Group to Acquire U.S. Cytec for $5.5 billion
Reports Say Amazon Suggests Dividing Airspace into Zones for Delivery Drones
Federal Reserve Expected to Stay Focused on Rate Hike Plan in September
Oil Prices Drop Near Four-Month Low as Supply Glut and Chinese Economy Increases
Reportedly A.G. Lafley to Pass Reigns of P&G CEO to David Taylor
Baidu Profits in Second Quarter Offset by Higher Expenses
Economists Predict Solid Revenue Growth for Vermont
Swiss bank Vontobel Announces 24 Percent Increase in Profit in the First Half of
President Obama Visits Kenya, His Father’s Birth Place
National Highway Traffic Safety Administration Slaps $105M Fine on Fiat Chrysler
Wealthy, Well Educated People in Early 60’s More at Risk of Harmful Drinking